PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
84706-3	1979	Confirmed rates of CR for 443 evaluable patients were 59% for 286 patients receiving the CHOP regimens and 59% for 157 patients receiving COP-Bleo.	Chromium	19-21	DNA damage inducible transcript 3	Homo sapiens	89-93	
84706-3	1979	Confirmed rates of CR for 443 evaluable patients were 59% for 286 patients receiving the CHOP regimens and 59% for 157 patients receiving COP-Bleo.	Chromium	19-21	caspase recruitment domain family member 16	Homo sapiens	138-141	
84706-6	1979	For patients with diffuse lymphomas the CR rate was higher with the CHOP programs (58%) than with COP-Bleo (44%) (p = 0.10).	Chromium	40-42	DNA damage inducible transcript 3	Homo sapiens	68-72	
84706-6	1979	For patients with diffuse lymphomas the CR rate was higher with the CHOP programs (58%) than with COP-Bleo (44%) (p = 0.10).	Chromium	40-42	caspase recruitment domain family member 16	Homo sapiens	98-101